Evidence map›Paper›PMID 27268103›Full record

SynthesisBMC infectious diseases2016

Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Anke L Stuurman, Marije Vonk Noordegraaf-Schouten, Femke van Kessel, Anouk M Oordt-Speets, Andreas Sandgren, Marieke J van der Werf

2 registry-linked trialsOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 45 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 5 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03783728 withdrawnnot on this mapstarted 2019, after this paper: background citation

Efficacy of Risk-Targeted Video Based Directly on Observed Therapy for Latent TB

TypeobservationalSponsorSt. Louis UniversityRan2019 to 2020Enrolled0ConditionsLatent TuberculosisArmsRifapentine 600 mg orally, Isoniazid 900 mg orally, Pyridoxine 50 mg orally
NCT05865626 nacompletednot on this mapstarted 2018, after this paper: background citation

A Pilot Study to Evaluate Video Observed Treatment Among Tuberculosis Patients From Lambaréné Using an Instant Messenger Application

TypeinterventionalSponsorCentre de Recherche Médicale de LambarénéRan2018 to 2022Enrolled30ConditionsTuberculosisArmsVOT with and without cash incentive
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 5 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.European respiratory review : an official journal of the European Respiratory Society · 2019
    Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Factors Associated With Discontinuation of Tuberculosis Preventive Treatment: Post Hoc Analysis of 2 Randomized, Controlled Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Managing tuberculosis infection among migrants from high-incidence tuberculosis countries: challenges, strategies and recommendations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anke L StuurmanPallas health research and consultancy BV, Rotterdam, The Netherlands.
Marije Vonk Noordegraaf-SchoutenPallas health research and consultancy BV, Rotterdam, The Netherlands.
Femke van KesselPallas health research and consultancy BV, Rotterdam, The Netherlands.
Anouk M Oordt-SpeetsPallas health research and consultancy BV, Rotterdam, The Netherlands.
Andreas SandgrenEuropean Centre for Disease Prevention and Control (ECDC), Tomtebodavägen 11a, Solna, 171 65, Sweden.
Marieke J van der WerfEuropean Centre for Disease Prevention and Control (ECDC), Tomtebodavägen 11a, Solna, 171 65, Sweden. marieke.vanderwerf@ecdc.europa.eu.
European Centre for Disease Prevention and Control · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLatent tuberculosis infection (LTBI) control relies on high initiation and completion rates of preventive treatment to preclude progression to tuberculosis disease. Specific interventions may improve initiation and completion rates. The objective was to systematically review data on determinants of initiation, adherence and completion of LTBI treatment, and on interventions to improve initiation and completion.

methodsA systematic review of the literature (PubMed, Embase) published up to February 2014 was performed. Relevant prospective intervention studies were assessed using GRADE.

resultsSixty-two articles reporting on determinants of treatment initiation and completion were included and 23 articles on interventions. Determinants of LTBI treatment completion include shorter treatment regimen and directly observed treatment (DOT, positive association), adverse events and alcohol use (negative association), and specific populations with LTBI (both positive and negative associations). A positive effect on completion was noted in intervention studies that used short regimens and social interventions; mixed results were found for intervention studies that used DOT or incentives.

conclusionLTBI treatment completion can be improved by using shorter regimens and social interventions. Specific needs of the different populations with LTBI should be addressed taking into consideration the setting and condition in which the LTBI treatment programme is implemented.

Indexed as

Patient ComplianceAntitubercular AgentsDirectly Observed TherapyHumansLatent TuberculosisMotivationProspective StudiesAntitubercular AgentsLatent tuberculosisRisk groupsTreatment adherenceTreatment completionTreatment initiationTuberculosis

Identifiers

PMID27268103
PMCPMC4897858
OpenAlexW2412311459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.